Shirai, K., Chen, T., Turk, M. J., Ramirez, D. E., Dragnev, C. P. C., Searles, T. G., . . . Huang, Y. H. Depletion of conventional CD4+ T cells is required for robust priming and dissemination of tumor antigen-specific CD8+ T cells in the setting of anti-CD4 therapy. BMJ Publishing Group.
Chicago Style (17th ed.) CitationShirai, Keisuke, et al. Depletion of Conventional CD4+ T Cells Is Required for Robust Priming and Dissemination of Tumor Antigen-specific CD8+ T Cells in the Setting of Anti-CD4 Therapy. BMJ Publishing Group.
MLA (9th ed.) CitationShirai, Keisuke, et al. Depletion of Conventional CD4+ T Cells Is Required for Robust Priming and Dissemination of Tumor Antigen-specific CD8+ T Cells in the Setting of Anti-CD4 Therapy. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.